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Introduction
Osseointegrated dental implants showed elevated
success rates on the long-term treatment in the last
ten years (1). These rates are referred to primary
stability, in turn, related to the quantity and quali-
ty of the receiving bone (1). However, despite of
the high success rates in the long-term, the risk of
peri-implantitis and implant failure is the main
complication of implantology (2). There are many
hypothesized causes of perimplantitis, but bacteri-
al colonization at the implant-abutment connec-
tion (IAC) is the most accreditate one (3). The
presence of a micro-gap at the IAC allows mi-
croorganisms to penetrate and colonize the inner
part of the implant leading to biofilm accumula-
tion and consequently to peri-implantitis develop-
ment (4-7).
The bacterial colonization at IAC level has an
important role in the onset of peri-implantitis
(5). In addiction the presence of oral diseases
such as periodontal disease, atrophy of the oral
mucosa, lesions of gastroesophageal reflux or
oral lichen planus may increase the risk peri-im-
plantitis (6-12).
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SUMMARY
Purpose. The aim of the present study is to evaluate the effectiveness of Ditron implants abutment connection (IAC) to
sealing the gap between two pieces.
Materials and methods. To identify the efficacy of a new IAC, the passage of genetically modified bacteria across IAC was
evaluated. A total of five Ditron Implants were used. All implants were immerged in a bacterial culture for forty-eight hours
and then bacteria amount was measured inside and outside IAC with Real-time PCR. Bacterial quantification was per-
formed by Real-Time Polymerase Chain Reaction using the absolute quantification with the standard curve method. 
Results. In all the tested implants, bacteria were found in the inner side, with a median percentage of 1.35%. The analy-
sis revealed that, in untreated implants, bacteria grew (internally and externally). Moreover, the difference between outer
and inner bacteria concentration was statistically significant at each time point. 
Conclusions. Ditron Implant IAC (MPI, Ditron Dental, Israel) is efficacy in reducing bacterial leakage.
Key words: implant-abutment connection, microbiological leakage, peri-implantitis, bone resorption.
Oral & Implantology  -  anno IX - n. 3/2016100
The presence of a gap in IAC is associated with a
significantly higher inflammatory cell infiltration
and bone loss (13).
In fact, some minutes after implant placement,
bacterial colonization of implant surfaces and
peri-implant tissues, immediately starts. The con-
nection between abutment and implant creates a
gap resulting in bacterial leakage and in an area of
inflamed soft tissue around the IAC. Prevention of
microbial leakage at the level of IAC is the main
aim for the construction of two-piece implant sys-
tems to avoid inflammation in peri-implant tis-
sues. This assumption is confirmed by the fact that
the percentage of peri-implantitis is minimized in
one piece implants, where there is no IAC and no
bacteria leakage (13).
Several in vitro studies have demonstrated that,
even if different internal connection designs were
proposed, no one prevented the passage of bacte-
ria along IAC in static or dynamic loading condi-
tions (14). Micro-leakage has been confirmed
bidirectional, from the inner parts of the implants
to the external environment and vice versa (15).
Some reports have been demonstrated that the use
of sealing materials, decontamination of the inner-
implant cavity, use of shape memory alloy and dif-
ferent connection geometries, have been unsuc-
cessful to prevent bacterial leakage. It is also
known that such diseases like oral mucositis, oral
dysplastic lesions, and burning mouth syndrome
may favour the onset of peri-implantitis (16-18).
Some studies tried to quantify microbiological
penetration between micro-gaps at IAC level, all
concluding that no one IAC has been demonstrat-
ed to perfectly close the gap between implant and
abutment, favoring the one set and maintenance of
peri-implantitis (19). Limited success has been
achieved in eliminating the implant-abutment gap
or simply avoiding its effects. Some different so-
lutions, such as inclusion of polymeric washers
between the parts of different implant systems, on-
ly decreased, but did not eliminate, bacterial con-
tamination (20).
Materials and methods
Molecular Precision Implant
(MPI) characteristics
MPI (Molecular Precision Implants, Ditron Den-
tal, Israel), due to its sophisticated control system
of the surfaces, provides to the implantologist a
safe and reliable implant, with a macro-morpholo-
gy designed to ensure a close contact with the sur-
rounding bone. 
The characteristics of this new implant are: Mole-
cuLockTM (seal between implant and abutment;
biomechanical design and 1 μ level production to
reduce micro gaps and micro movement risks),
surface treatment (Al2O3 surface blasting and
double-acid etching; high purity cleaning proce-
dures), implant body (high initial stability even in
compromised bone situations; expanding tapered
implant body, with double-thread self-tapping de-
sign, condensing bone gradually, to enhance pri-
mary stability; insertion rate of the Molecular Pre-
cision implants of 2.2 mm per revolution),
Restorative Platform (a beveled collar shifting the
implant-abutment junction inward, in order to
achieve platform-switching configuration; plat-
form switching generating a perfect environment
for the soft tissue growth and helps prevent bone
resorption), assisted osteointegration (Unique
Spherical Helix Chamber forming a localized in-
frastructure that serves as a scaffold for promoting
wound healing and bone formation from existing
osteoblasts), Apex design (Apex with self-tapping
drilling blades enables smaller osteotomy; the
self-tapping function supporting a precise adapta-
tion of the implant thread to the bone, thus pro-
viding optimal primary stability; improved ease of
insertion and allowing mild direction refinement
during the initial stages of insertion).
Implant preparation
In order to size up the ability of the implant to iso-
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late the heart of the device from the external envi-
ronment, we evaluated the passage of modified
bacteria across the joint of the implant. The pecu-
liarity of these bacteria is that they contain syn-
thetic DNA target sequences in their plasmid. In
detail, the broth contains two bacterial species (P.
gingivalis and T. forsythia) and two plasmids for
antibiotic selection (Kanamycin and Ampicillin).
Bacteria were cultured in lysogeny broath (LB)
containing both Kanamycin and Ampicillin (at a
final concentration of 50ug/ml) at 37°C for 12-
18hr in a shacking incubator. Five molecular pre-
cision implants (MPI, Ditron Dental, Israel) were
used in this study. Few microliters of LB with an-
tibiotics were put inside the implants (Figure 1a).
The implants and the abutment are screwed with a
force of 35 Newton (Figure 1b).
Few microliters of this culture were used to “con-
taminate” fresh LB with antibiotics contained in a
microcentrifuge tube together with the implant.
Tubes were then let at 37°C for forty-eight hours
in a heater, in order to allow bacterial growth and
their hypothetical passage within the implant (Fig-
ure 1c). Inside the implant, instead, we just put LB
and antibiotics without bacteria.
To be sure that there were no contaminations, a
negative control containing only LB and antibi-
otics, was prepared.
Forty-eight hours later, implants were opened and
samples were collected by dipping a paper probe
in both the sites containing LB (external and inter-
nal to the implant) for each implant, and in the
negative control too (Figure 1d).
Figure 1
a) Few microliters of LB with antibiotics were put inside
the implants; b) The implant and the abutment are
screwed with a force of 35 Newton; c) Tubes let at
37°C for 48h in a heater, in order to allow bacterial
growth and their hypothetical passage within the im-
plant. Inside the implant, instead, were just put LB and
antibiotics without bacteria; d) Implants opened and
samples collected by dipping a paper probe in both the
sites containing LB (external and internal to the im-
plant) for each implant, and in the negative control too
forty-eight hours later.
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Dna extraction
Once collected, paper probe were put on a new mi-
crocentrifuge tube and processed for bacterial
DNA extraction, by using the GenEluteTM Bacte-
rial Genomic DNA Kit (Sigma-Aldrich, St., St.
Louis, MO, USA), following the manufacturing
procedures. Briefly, samples were incubated with
lysozyme and, subsequently with proteinase K to
isolate DNA. Once extracted, DNA was purified
by spin-column method. 
Real-time polymerase chain
reaction
Bacterial quantification was performed by Real-Time
Polymerase Chain Reaction using the absolute
quantification with the standard curve method. 
Primers and probes oligonucleotides for P. gingivalis
and T. forsythia were designed basing on 16S
rRNA gene sequences of the Human Oral Micro-
biome Database (HOMD 16S rRNA RefSeq Version
10.1). 
For the quantitative analysis, plasmid (Eurofin
MWG Operon, Ebersberg Germany) containing the
specific DNA target sequence was employed as stan-
dard. 
All reactions were performed in duplex, in 20ul fi-
nal volumes, with 2X TaqMan Universal PCR
master mix (Applied Biosystems, Foster City, CA,
USA) and 50nM concentration of each primers
and 200nM of the probes. Amplifications were
carry out by using the ABI PRISM 7500 (Applied
Biosystems, Foster City, CA, USA).
Statistical analysis
To evaluate if the difference in viability among
outside and inside the implant was statistically sig-
nificant, we applied Student’s t-test on average
bacteria quantification at each time point. 
Results
Bacteria quantification is reported in Table 1. In
all the tested implants, bacteria were found in the
inner side, with a median percentage of 1.35%.
The analysis revealed that in both cases (internal-
ly and externally), bacteria grew for the first forty-
eight hours but subsequently they started to dye,
probably as a consequence of nutrient consump-
tion. Moreover, the difference between outer and
inner bacteria concentration was statistically sig-
nificant at each time point. 
Discussion 
It is clear that peri-implantitis occurs due to the
presence of pathogenic micro-organisms coloniz-
Table 1 - Bacterial quantification and calculation of their entry’s percentage. 
Outside Inside
Implant P. Gingivalis + T. forsythia P. Gingivalis + T. forsythia Passage of bacteria from outside
Absolute Quantification Absolute Quantification to inside the implant (%)
DITRON 1 922154 35420 3,8
DITRON 2 372115 0 0,0
DITRON 3 790818 9743 1,2
DITRON 4 1000226 4214 0,4
Negative Control 0 0 0
original research article
Oral & Implantology  -  anno IX - n. 3/2016 103
ing the surrounding implant area and the suppres-
sion or eradication of these microbes result in pre-
vention of peri-implantitis (1). The main cause of
peri-implantitis consists in the passage of patho-
genic bacteria in the abutment-implant gap. The
inner spaces were easily colonized, and bacteria
may leak out from these spaces through the IAC
into the peri-implant area. The formation of a
biofilm around the implant plays a fundamental
role in the onset of peri-implantitis (21). In any
case, the peri-implantitis is associated with gram-
negative bacteria similar to those that cause peri-
odontal disease (3). The peri-implantitis, such as
periodontal disease is the result of the bacterial in-
sult and the subsequent host response. Some stud-
ies have shown that bacterial species of periodon-
tal disease are very similar to those that cause peri-
implantitis (19). For which it is clear that blocking
the passage of bacteria in the peri-implant space is
essential to prevent peri-implantitis. The use of a
new implant-abutment connection can represent a
valid solution to prevent the development of peri-
implantitis. The potential benefits of a new IAC
include improved patient compliance and an easi-
er access to implant-abutment space (20-26). The
use of this new IAC may influence prosthodontic
(27-30) and endodontic (31, 32) clinical out-
comes. In addiction the use of general and local
anesthesia may have side effects (33-36) and se-
vere complications (37).
The adoption of a new IAC have been demon-
strated to dramatically reduce the bacterial leak-
age. This new IAC shows to reduce bacterial leak-
age for most perio-pathogens, and at the same
time, exhibits negligible impact on the microflora
residing in other parts of the body.
Our study evaluated the efficacy of this new IAC
in preventing bacterial leakage infiltrated between
implant and abutment, considered the primary eti-
ological factors for peri-implantitis.
Microbiological testing was thought appropriate
to evaluate the effect of this new IAC on subgin-
gival microbial population. It is well known that
both P. gingivalis and T. forsythia occur concomi-
tantly with the clinical signs of bone resorption
surrounding implant. They appear closely ‘linked’
topologically in the developing biofilm, exhibiting
an in vitro ability to produce a number of outer
membrane-associated proteinases. They are con-
sidered the first pathogens involved in the clinical
destruction of peri-implant bone and in the local
development of peri-implantitis. Our results
demonstrated that this new IAC performs very
well in preventing bacteria proliferation of the mi-
crobial species which comes in contact with it. 
Molecular precision implant-abutment connection
(MPI, Ditron Dental, Israel) is efficacy in reducing
bacterial leakage. In fact, even if the main factor
for survival rate of implants is the quality of bone
of receiving sites, the bacteria of peri-implantitis
may be the main cause of failure of implants. In
spite of the limits of our study, none IAC has been
demonstrated to perfectly close the gap between
implant and abutment.
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